Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Federal Trade Commission
AstraZeneca
Medtronic
Deloitte

Generated: May 23, 2019

DrugPatentWatch Database Preview

Actavis Labs Company Profile

« Back to Dashboard

What is the competitive landscape for ACTAVIS LABS, and what generic and branded alternatives to ACTAVIS LABS drugs are available?

ACTAVIS LABS has one hundred and eight approved drugs.

There are three tentative approvals on ACTAVIS LABS drugs.

Summary for Actavis Labs
US Patents:0
Tradenames:82
Ingredients:75
NDAs:108

Drugs and US Patents for Actavis Labs

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Fl Inc DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE doxylamine succinate; pyridoxine hydrochloride TABLET, DELAYED RELEASE;ORAL 205811-001 Aug 19, 2016 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Actavis Labs Fl Inc BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE benazepril hydrochloride; hydrochlorothiazide TABLET;ORAL 076342-002 Feb 11, 2004 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Actavis Labs Fl Inc FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE fosinopril sodium; hydrochlorothiazide TABLET;ORAL 076608-002 Dec 3, 2004 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Actavis Labs Fl Inc GLIMEPIRIDE glimepiride TABLET;ORAL 076995-002 Apr 27, 2010 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Actavis Labs Fl Inc OXYCODONE AND ASPIRIN aspirin; oxycodone hydrochloride TABLET;ORAL 090084-001 Mar 22, 2011 AA RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Actavis Labs Fl Inc METHYLPHENIDATE HYDROCHLORIDE methylphenidate hydrochloride FOR SUSPENSION, EXTENDED RELEASE;ORAL 206049-001 May 17, 2018 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Expired US Patents for Actavis Labs

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Actavis Labs Ut Inc LOXITANE IM loxapine hydrochloride INJECTABLE;INJECTION 018039-001 Approved Prior to Jan 1, 1982 3,546,226 ➤ Try a Free Trial
Actavis Labs Ut Inc EMLA lidocaine; prilocaine CREAM;TOPICAL 019941-001 Dec 30, 1992 4,529,601 ➤ Try a Free Trial
Actavis Labs Ut Inc EMLA lidocaine; prilocaine CREAM;TOPICAL 019941-001 Dec 30, 1992 4,562,060 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for ACTAVIS LABS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Julphar
Fish and Richardson
Boehringer Ingelheim
Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.